Clinical Trial Update: Follicular Lymphoma IV/SC Rituximab Therapy (FLIRT) [Phase 3]

View source ↗

Summary

Phase 3 trial update for Follicular Lymphoma evaluating IV/SC Rituximab therapy (FLIRT) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Follicular Lymphoma | Phase 3 | Status: COMPLETED